Because AAVs may also be injected to other tissues, vascular pathologies in other organs, such as cerebral cavernous malformations,60 could in the future also be studied with the help of our VEGF-expressing AAV. The gene discussed is VEGFA; the disease is cerebral cavernous malformation.